張翺 醫生
Dr. Cheung Ngo
精神科專科醫生
Specialist in Psychiatry
香港大學內外全科醫學士
香港大學分子及診斷病理學深造文憑
香港中文大學基因組學及生物信息學理學碩士
香港精神科醫學院院士
香港醫學專科學院院士(精神科)
Bachelor of Medicine and Bachelor of Surgery, The University of Hong Kong
Postgraduate Diploma in Molecular and Diagnostic Pathology, The University of Hong Kong
Master of Science in Genomics and Bioinformatics, The Chinese University of Hong Kong
Fellow of the Hong Kong College of Psychiatrists
Fellow of the Hong Kong Academy of Medicine (Psychiatry)


學術著作
Cheung Glutamatergic Regimen and Hypotheses
-
Cheung N (2026) DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs. Front. Psychiatry 17:1751605. doi: 10.3389/fpsyt.2026.1751605
-
Cheung N. (2026). The Cheung Glutamatergic Regimen as a candidate for primary and secondary prevention of Alzheimer's disease onset. Journal of Alzheimer's disease reports, 10, 25424823261433953. https://doi.org/10.1177/25424823261433953
-
Cheung N. (2026). A Developmental Taxonomy of Autism and the Precision Timing of the Cheung Glutamatergic Regimen. Cureus, 18(4), e107120. https://doi.org/10.7759/cureus.107120
CGR Case Reports and Series
-
Cheung, N. (2026). Oral glutamatergic modulation with dextromethorphan and piracetam for refractory bipolar disorder with obsessive-compulsive disorder: Three consecutive cases from routine practice. Journal of Clinical Psychiatry, 87(2), Article 25cr16262. https://doi.org/10.4088/JCP.25cr16262
-
Cheung N (2026) Case Report: Oral glutamatergic augmentation for trauma-related disorders with fluoxetine-/bupropion-potentiated dextromethorphan ± piracetam: a four-patient case series. Front. Psychiatry 17:1752101. doi: 10.3389/fpsyt.2026.1752101
-
Cheung N (2026) Glutamatergic Enhancement Using As-Needed Dextromethorphan and Piracetam in a Stimulant-Partially Responsive Adult With ADHD: A Single-Case Report. Cureus 18(2): e104031. doi:10.7759/cureus.104031
-
Cheung N (2026) Transient Mood Elevation Without a Manic Switch: Goldenseal-Augmented Oral Glutamatergic Regimen in Bipolar Depression With Comorbid Obsessive-Compulsive Disorder (OCD). Cureus 18(2): e104209. doi:10.7759/cureus.104209
-
Cheung N (2026) Marked Improvement in Treatment-Intolerant Obsessive-Compulsive Disorder in an Adolescent Using a Glutamatergic Regimen With Dextromethorphan, Piracetam, and Goldenseal Root. Cureus 18(3): e104617. doi:10.7759/cureus.104617
-
Cheung N (2026) Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features. Cureus 18(3): e105367. doi:10.7759/cureus.105367
-
Cheung N (2026) Longitudinal Management of Post-traumatic Brain Injury Bipolar-Spectrum Disorder With Low-Dose Oral Glutamatergic Augmentation: Extended Follow-Up Revealing Induction, Overshoot, Stabilization, and Transition to PRN Maintenance. Cureus 18(5): e108595. doi:10.7759/cureus.108595
-
Cheung N (2026) Longitudinal Outcomes of Oral Glutamatergic Augmentation in Trauma-Related Dissociation: A Six-Month Case Study. Cureus 18(5): e108751. doi:10.7759/cureus.108751
Genomics
-
Cheung N (2026) Synaptic Plasticity Fragility Underlies a Microglial Pruning Continuum in Major Depressive Disorder and Amyotrophic Lateral Sclerosis. Cureus 18(4): e107259. doi:10.7759/cureus.107259
Computational Psychiatry
-
Cheung N. (2026). Divergent Mechanisms of Antidepressant Efficacy: A Unified Computational Comparison of Synaptogenesis, Stabilization, and Tonic Inhibition in a Model of Depression. Cureus, 18(3), e105040. https://doi.org/10.7759/cureus.105040
